NLRP3 and chronic obstructive pulmonary disease: Exposure of human lung fibroblasts to particulate matter (PM) leads to the activation of the SIRT1-SREBP1-PIR/NLRP3 inflammasome axis by inhibiting SIRT1, which can serve as therapeutic targets for PM-related COPD [57].